Early Predictors of Heart Failure Progression in Patients After Myocardial Infarction

Aim      To identify early predictors for progression of chronic heart failure (CHF) in patients with ST-segment elevation myocardial infarction (STEMI).

Material and methods  The study included 113 patients with STEMI aged 52 (95 % confidence interval, 36 to 65) years. 24-h ECG monitoring was performed with assessment of ventricular late potentials, QT dispersion, heart rhythm turbulence (HRT), and heart rhythm variability (HRV); XStrain 2D echocardiograpy with determination of volumetric parameters, myocardial strain characteristics and velocities; and measurement of brain natriuretic peptide (BNP) concentrations. The endpoint was CHF progression during 48 weeks of follow-up, which was observed in 26 (23 %) patients. Based on the outcome, two groups were isolated, with CHF progression (Prg) (26(23%)) and with a relatively stable CHF postinfarction course (Stb) (87 (77 %)).

Results At 12 weeks following MI, the Prg group showed increases in left ventricular (LV) end-diastolic dimension (EDD) (р<0.05) and end-diastolic and end-systolic volumes (EDV, ESV), (р<0.01), and EDV and ESV indexes (EDVi and ESVi, р<0.01). In this group, global longitudinal strain (GLS) was decreased at 24 weeks (р<0.05) and global radial strain (GRS) was decreased at 48 weeks (р=0.0003). In the Prg group, values of strain parameters (GLS, global circular strain (GCS), and GRS) were lower at all times. At 7-9 days, 24 weeks, and 48 weeks, the proportion of patients with pathological HRT was higher in the Prg group (38, 27, and 19 % for the Prg group vs 14 % (р=0.006); 3,4 % (р=0.001), and 2.3 % (р=0.002) for the Stb group, respectively). Only in the Stb group, increases in HRV were observed (SDNNi by 13 % (р=0.001), rMSSD by 24 % (р=0.0002), TotP by 49 % (р=0.00002), VLfP by 23 % (р=0.003), LfP by 22 % (р=0.008), and HfP by 77 % (р=0.002). At 7-9 days of MI, the Stb group had greater values of SDANN (р=0.013) and HfP (р=0.01). CHF progression correlated with abnormal values of turbulence onset (TO), disturbed HRT, increased BNP levels and LV ESD, and low values of GLS, GCS, and GRS. Combined assessment of HRT, LV ESD, and GLS at 7–9 days after STEMI allows identifying patients with high risk for CHF progression in the next 48 weeks.

Conclusion      The markers for CHF progression after STEMI include abnormal TO values, disturbed HRT, increased BNP levels and LV ESD, and low values of GLS, GCS, and GRS. The multifactor logistic regression analysis revealed early predictors of CHF in the postinfarction period, including abnormal TO, increased LV ESD, and reduced GLS.

1. Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Y.L., Vasyuk Y.A., Garganeeva A.A., Gendlin G.E., et al. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018; 58(6S): 8-158. https://doi.org/10.18087/cardio.2475.

2. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016; 37 (27):2129-200. https://doi.org/10.1093/eurheartj/ehw128.

3. Fomin I.V. Chronic heart failure in the Russian Federation: what we know and should do today. Russian journal of cardiology. 2016; (8): 7-13. https://doi.org/10.15829/1560-4071-2016-8-7-13.

4. Ziaeian B., Fonarow G.C. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016; 13(6): 368-78. https://doi.org/10.1038/nrcardio.2016.25.

5. Juilliere Y, Cambou J.P., Bataille V., Mulakb G., Galinierd M., Gibeline P., et al. Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry. Rev Esp Cardiol, 2012; 65: 326-333. https://doi.org/10.1016/j.recesp.2011.10.027.

6. Lesyuk W., Kriza C., Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a systematic review 2004-2016. BMC Cardiovasc Disord. 2018; 18(1): 74. https://doi.org/10.1186/s12872-018-0815-3.

7. Fabian I., Pugliese N. R., Santini V. Speckle-Tracking Imaging, Principles and Clinical Applications: A Review for Clinical Cardiologists. Echocardiography in Heart Failure and Cardiac Electrophysiology. IntechOpen, 2016: 85-114. https://doi.org/10.5772/64261.

8. Makarov L.M. Holter Monitoring - 4th ed. M.: Medpraktika-M., 2017: 504 p.

9. Bubnova M.G., Barbarash O.L., Doleckij A.A., Krasnickij V.B., Lebedeva E.V., Lyamina N.P., et al. Acute myocardial infarction with ST segment elevation of the electrocardiogram: rehabilitation and secondary prevention. Russian clinical guidelines. Russian journal of cardiology. 2015; (1): https://doi.org/.DOI: 10.15829/1560-4071-2015-1-6-52.

10. Lang TA. How to describe the statistics in medicine. A guide for authors, editors and reviewers. M.: Prakticheskaya Medicina, 2011, r. 480.

11. Order of the Ministry of Health and Social Development of the Russian Federation of July 11, 2008 No. 331 "On the procedure for organizing monitoring of the implementation of measures aimed at improving the provision of medical care to patients with vascular diseases."

12. Barbarash O.L., Kashtalap V.V., Kochergina A.M., Leonova V.O., Erlikh A.D. Management of patients with ST-segment elevation acute coronary syndrome in interventional cardiology units: record-3 registry data. Fundamental and Clinical Medicine. 2016; 1(3): 6-13. ISSN:2500-0764.

13. Wang T.Y., Nallamothu B.K., Krumholz H.M., Li S., Roe M.T., Jollis J.G. et al. Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. JAMA 2011; 305(24): 2540-2547. https://doi.org/10.1253/circj.CJ-16-0204.

14. Priori S.G., Blomstrom C., Mazzanti A., Blom N.A., Borggrefe M., Camm J. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36: 2793-867. https://doi.org/10.1093/europace/euv319.

15. Gasparyan A.Z., Shlevkov N.B., Skvortsov A.A. Possibilities of modern biomarkers for assessing the risk of developing ventricular tachyarrhythmias and sudden cardiac death in patients with chronic heart failure. Kardiologiia. 2020;60(4):101-108 https://doi.org/10.18087/cardio.2020.4.n487.

16. Haugaa Kr.H., Grenne B.L., Eek Ch.H, Ersboll M., Valeur N., Svendsen J.H. et al. Strain Echocardiography Improves Risk Prediction of Ventricular Arrhythmias After Myocardial Infarction. JACC: Cardiovascular Imaging. 2013; 6 (8): 841-50. https://doi.org/10.1016/j.jcmg.2013.03.005.

17. Stanton T, Leano R, Marwick TH. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circulation. Cardiovascular Imaging. 2009; 2(5):356-64. https://doi.org/10.1161/ CIRCIMAGING.109.862334.

18. Vasyuk Y.A., Nesvetov V.V., Yushuk E.N., Scherbak M.M. Clinical Capabilities and Limitations in the Use of Modern Technologies in Echocardiography. Kardiologiia. 2019;59(7):68-75. https://doi.org/10.18087/cardio.2019.7.2651.

19. Zhang KW, French B, May Khan A, Plappert T, Fang JC, Sweitzer NK et al. Strain Improves Risk Prediction Beyond Ejection Fraction in Chronic Systolic Heart Failure. Journal of the American Heart Association. 2014; 3(1):e000550. https://doi.org/10.1161/JAHA.113.000550.

20. Nikiforov V.S., Nikishchenkova Yu.V. Modern Possibilities of Speckle Tracking Echocardiography in Clinical Practice. Rational Pharmacotherapy in Cardiology. 2017;13(2):248-55. https://doi.org/10.20996/1819-6446-2017-13-2-248-255.

21. Obrezan A.G., Baranov D.Z. Myocardial Strain Properties in Patients with Chronic Heart Failure. Kardiologiia. 2019; 59(8): 88-96. https://doi.org/10.18087/cardio.2019.8.2579.

22. Fazlinezhad A., Khadem-Rezaeian M., Yousefzadeh H. et al. Plasma brain natriuretic peptide (BNP) as an indicator of left ventricular function, early outcome and mechanical complications after acute myocardial infarction. Clin. Med. Insights. Cardiol. 2011; 5: 77-83. https://doi.org/10.4137/CMC.S7189.

23. Steinberg J.S., Varma N., Cygankiewicz I. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiacmonitoring/telemetry. Heart Rhythm. 2017; 14 (7): 55-96. https://doi.org/10.1016/j.hrthm.2017.03.038.

24. La Rovere M.T., Pinna G.D., Maestri R. et al. GISSI-HF Investigators. Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: Still a place in prognostication? Data from the GISSI-HF trial. European Journal of Heart Failure. 2012; 14: 1410-1419.

25. Cygankiewicz I. Heart rate turbulence. Progress in Cardiovascular Diseases. 2013; 56: 160-171. https://doi.org/10.1016/j.pcad.2013.08.002.